Causal role of alcohol consumption in an improved lipid profile: The atherosclerosis risk in communities (aric) study

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Vu, Khanh N ^a   Ballantyne, Christie M ^b,c   Hoogeveen, Ron C ^b,c   Nambi, Vijay ^b,c,d   Volcik, Kelly A ^e   Boerwinkle, Eric ^a,b   Morrison, Alanna C ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ADH1B PROTEIN, HUMAN; ADH1C PROTEIN, HUMAN; ALCOHOL DEHYDROGENASE IV;

ACETALDEHYDE DEHYDROGENASE GENE; ADH1B GENE; ADH1C GENE; ADH4 GENE; ADULT; ALCOHOL CONSUMPTION; ALCOHOL DEHYDROGENASE GENE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; LIPID ANALYSIS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PROSPECTIVE STUDY; SCORING SYSTEM; BLOOD; CLINICAL TRIAL; DRINKING BEHAVIOR; GENETICS; MIDDLE AGED; MULTICENTER STUDY;

ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; ATHEROSCLEROSIS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED;

EID: 84959422709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148765     Document Type: Article

References (94)

1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342: d671. doi:10.1136/bmj.d671PMID: 21343207.
2. Han H, Wang H, Yin Z, Jiang H, Fang M, Han J. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis. Gene. 2013; 526(2):134-41. doi:10.1016/j.gene.2013.05.002PMID: 23685282.
3. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001; 344(8):549-55. PMID: 11207350.
4. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011; 342:d636. doi:10.1136/bmj.d636 PMID: 21343206.
5. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319 (7224):1523-8. PMID: 10591709.
6. Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP. Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: The Stanford Five City Project. Prev Med. 2000; 31(4):346-56. PMID: 11006059.
7. Muth ND, Laughlin GA, von Muhlen D, Smith SC, Barrett-Connor E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: The Rancho Bernardo Study. Br J Nutr. 2010; 104(7):1034-42. doi:10.1017/S0007114510001595PMID: 20426890.
8. Wakabayashi I. Associations of alcohol drinking and cigarette smoking with serum lipid levels in healthy middle-aged men. Alcohol Alcohol. 2008; 43(3):274-80. doi:10.1093/alcalc/agn005 PMID: 18283096.
9. Rakic V, Puddey IB, Dimmitt SB, Burke V, Beilin LJ. A controlled trial of the effects of pattern of alcohol intake on serum lipid levels in regular drinkers. Atherosclerosis. 1998; 137(2):243-52. PMID: 9622267.
10. Wakabayashi I. Relationship between alcohol intake and lipid accumulation product in middle-aged men. Alcohol Alcohol. 2013; 48(5):535-42. doi:10.1093/alcalc/agt032 PMID: 23592501.
11. Klop B, do Rego AT, Cabezas MC. Alcohol and plasma triglycerides. Curr Opin Lipidol. 2013; 24 (4):321-6. doi:10.1097/MOL.0b013e3283606845 PMID: 23511381.
12. Whitfield JB, Heath AC, Madden PA, Pergadia ML, Montgomery GW, Martin NG. Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcohol Clin Exp Res. 2013; 37(4):575-86. doi:10.1111/acer.12015 PMID: 23134229.
13. Brinton EA. Effects of ethanol intake on lipoproteins. Current atherosclerosis reports. 2012; 14(2):108- 14. doi:10.1007/s11883-012-0230-7 PMID: 22350634.
14. Kechagias S, Zanjani S, Gjellan S, Leinhard OD, Kihlberg J, Smedby O, et al. Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study. Ann Med. 2011; 43 (7):545-54. doi:10.3109/07853890.2011.588246 PMID: 21599573.
15. Rifler JP, Lorcerie F, Durand P, Delmas D, Ragot K, Limagne E, et al. A moderate red wine intake improves blood lipid parameters and erythrocytes membrane fluidity in post myocardial infarct patients. Mol Nutr Food Res. 2012; 56(2):345-51doi:10.1002/mnfr.760 PMID: 22419533.
16. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E. Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol. 2008; 18(2):101-7. PMID: 17855114.
17. Naimi TS, Brown DW, Brewer RD, Giles WH, Mensah G, Serdula MK, et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med. 2005; 28 (4):369-73. PMID: 15831343.
18. Mukamal KJ, Ding EL, Djousse L. Alcohol consumption, physical activity, and chronic disease risk factors: a population-based cross-sectional survey. BMC Public Health. 2006; 6:118. PMID: 16670030.
19. Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007; 16(4):309-30. PMID: 17715159.
20. Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011; 40(3):755-64. doi:10.1093/ije/dyr036PMID: 21414999.
21. Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011; 40(3):740-52. doi:10.1093/ije/dyq151 PMID: 20813862.
22. Murray MP. Avoiding invalid instruments and coping with weak instruments. The Journal of Economic Perspectives. 2006; 20(4):111-32.
23. Thanassoulis G. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease. Can J Cardiol. 2013; 29(1):30-6. doi:10.1016/j.cjca.2012.09.014PMID: 23199790.
24. Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, Brookhart MA. Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol. 2009; 169(3):273-84. doi:10.1093/aje/kwn299PMID: 19033525.
25. Baum CF, Schaffer ME, Stillman S. Enhanced routines for instrumental variables/GMM estimation and testing. Stata Journal. 2007; 7(4):465-506.
26. Baum C. Instrumental variables and panel data methods in economics and finance. Boston College and DIW Berlin. 2009.
27. Burgess S, Thompson SG. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol. 2013; 42(4):1134-44. doi:10.1093/ije/dyt093 PMID: 24062299.
28. Lawlor DA, Nordestgaard BG, Benn M, Zuccolo L, Tybjaerg-Hansen A, Davey Smith G. Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study. Eur Heart J. 2013; 34(32):2519- 28. doi:10.1093/eurheartj/eht081PMID: 23492672.
29. Au Yeung SL, Jiang C, Cheng KK, Cowling BJ, Liu B, Zhang W, et al. Moderate alcohol use and cardiovascular disease from Mendelian randomization. PLOS One. 2013; 8(7):e68054. doi:10.1371/journal.pone.0068054 PMID: 23874492.
30. Martin SS, Jones SR, Toth PP. High-density lipoprotein subfractions: current views and clinical practice applications. Trends Endocrinol Metab. 2014; 25(7):329-36. doi:10.1016/j.tem.2014.05.005 PMID: 24931711.
31. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989; 129(4):687-702. PMID: 2646917.
32. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: U.S. Government Printing Office; December 2010.
33. Agrawal A, Freedman ND, Cheng YC, Lin P, Shaffer JR, Sun Q, et al. Measuring alcohol consumption for genomic meta-analyses of alcohol intake: opportunities and challenges. Am J Clin Nutr. 2012; 95 (3):539-47. doi:10.3945/ajcn.111.015545PMID: 22301922.
34. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 2003; 289(19):2560-71. PMID: 12748199.
35. Wakabayashi I, Kobaba-Wakabayashi R, Masuda H. Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Diabetes Care. 2002; 25(7):1223-8. PMID: 12087023.
36. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983; 29(6):1075-80. PMID: 6851096.
37. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, et al. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984; 22(2):165-74. PMID: 6716056.
38. Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ. HDL cholesterol quantitation by phosphotungstate- Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol. 1982; 78(5):718-23. PMID: 6182791.
39. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM Jr., et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993; 13(8):1139-58. PMID: 8343489.
40. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. PMID: 4337382.
41. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003; 34(3):623-31. PMID: 12624282.
42. Gaubatz JW, Chari MV, Nava ML, Guyton JR, Morrisett JD. Isolation and characterization of the two major apoproteins in human lipoprotein [a]. J Lipid Res. 1987; 28(1):69-79. PMID: 2951469.
43. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2012; 125(2):241-9. doi10.1161/CIRCULATIONAHA.111.045120 PMID: 22128224.
44. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: The Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014; 34(5):1069-77. doi10.1161/ATVBAHA.114.303284 PMID: 24558110.
45. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health. 2006; 29(4):245- 54. PMID: 17718403.
46. Hurley TD, Edenberg HJ. Genes encoding enzymes involved in ethanol metabolism. Alcohol Res. 2012; 34(3):339-44. PMID: 23134050.
47. Rietschel M, Treutlein J. The genetics of alcohol dependence. Ann N Y Acad Sci. 2013; 1282:39-70. doi:10.1111/j.1749-6632.2012.06794.x PMID: 23170934.
48. Gelernter J, Kranzler HR, Sherva R, Almasy L, Koesterer R, Smith AH, et al. Genome-wide association study of alcohol dependence:significant findings in African- And European-Americans including novel risk loci. Mol Psychiatry. 2014; 19(1):41-9. doi:10.1038/mp.2013.145PMID: 24166409.
49. Macgregor S, Lind PA, Bucholz KK, Hansell NK, Madden PA, Richter MM, et al. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet. 2009; 18(3):580-93. doi:10.1093/hmg/ddn372 PMID: 18996923.
50. Luo X, Kranzler HR, Zuo L, Yang BZ, Lappalainen J, Gelernter J. ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies. Pharmacogenet Genomics. 2005; 15(11):755-68. PMID: 16220108.
51. Ferrari P, McKay JD, Jenab M, Brennan P, Canzian F, Vogel U, et al. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Eur J Clin Nutr. 2012; 66(12):1303-8. doi:10.1038/ejcn.2012.173PMID: 23149980.
52. Way M, McQuillin A, Saini J, Ruparelia K, Lydall GJ, Guerrini I, et al. Genetic variants in or near ADH1B and ADH1C affect susceptibility to alcohol dependence in a British and Irish population. Addict Biol. 2015; 20(3):594-604. doi:10.1111/adb.12141 PMID: 24735490.
53. Biernacka JM, Geske JR, Schneekloth TD, Frye MA, Cunningham JM, Choi DS, et al. Replication of genome wide association studies of alcohol dependence: support for association with variation in ADH1C. PLOS One. 2013; 8(3):e58798. doi:10.1371/journal.pone.0058798 PMID: 23516558.
54. Li D, Zhao H, Gelernter J. Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. Biol Psychiatry. 2011; 70(6):504-12. doi10.1016/j.biopsych.2011.02.024 PMID: 21497796.
55. Toth R, Fiatal S, Petrovski B, McKee M, Adany R. Combined effect of ADH1B RS1229984, RS2066702 and ADH1C RS1693482/RS698 alleles on alcoholism and chronic liver diseases. Dis Markers. 2011; 31(5):267-77. doi:10.3233/DMA-2011-0828 PMID: 22048268.
56. Norden-Krichmar TM, Gizer IR, Wilhelmsen KC, Schork NJ, Ehlers CL. Protective variant associated with alcohol dependence in a Mexican American cohort. BMC Med Genet. 2014; 15:136. doi:10.1186/s12881-014-0136-zPMID: 25527893.
57. Bierut LJ, Goate AM, Breslau N, Johnson EO, Bertelsen S, Fox L, et al. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol Psychiatry. 2012; 17(4):445-50. doi:10.1038/mp.2011.124 PMID: 21968928.
58. Li D, Zhao H, Gelernter J. Further clarification of the contribution of the ADH1C gene to vulnerability of alcoholism and selected liver diseases. Hum Genet. 2012; 131(8):1361-74doi:10.1007/s00439-012-1163-5 PMID: 22476623.
59. Agrawal A, Bierut LJ. Identifying genetic variation for alcohol dependence. Alcohol Res. 2012; 34 (3):274-81. PMID: 23134043.
60. Agrawal A, Verweij KJ, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG, et al. The genetics of addiction-a translational perspective. Transl Psychiatry. 2012; 2:e140. doi:10.1038/tp.2012.54 PMID: 22806211.
61. Zuccolo L, Fitz-Simon N, Gray R, Ring SM, Sayal K, Smith GD, et al. A non-synonymous variant in ADH1B is strongly associated with prenatal alcohol use in a European sample of pregnant women. Hum Mol Genet. 2009; 18(22):4457-66. doi:10.1093/hmg/ddp388 PMID: 19687126.
62. Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD, et al. Best practices and joint calling of the HumanExome BeadChip: The CHARGE Consortium. PLOS One. 2013; 8(7):e68095. doi:10.1371/journal.pone.0068095 PMID: 23874508.
63. Genome-Wide Human SNP Array 6.0. Available: http://www.affymetrix.com/catalog/131533/AFFY/Genome-Wide+Human+SNP+Array+6.0#1-1.
64. Gene Expression Analysis Using TaqMan1 Assays: Life Technologies. Available: http://www.lifetechnologies.com/us/en/home/life-science/pcr/real-time-pcr/real-time-pcr-assays/taqman-geneexpression.html.
65. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013; 45(11):1274-83. doi:10.1038/ng.2797 PMID: 24097068.
66. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466(7307):707-13. doi:10.1038/nature09270 PMID: 20686565.
67. Adeyemo A, Bentley AR, Meilleur KG, Doumatey AP, Chen G, Zhou J, et al. Transferability and fine mapping of genome-wide associated loci for lipids in African Americans. BMC Med Genet. 2012; 13:88. doi:10.1186/1471-2350-13-88 PMID: 22994408.
68. Rasmussen-Torvik LJ, Pacheco JA, Wilke RA, Thompson WK, Ritchie MD, Kho AN, et al. High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE. Clin Transl Sci. 2012; 5(5):394-9. doi:10.1111/j.1752-8062.2012.00446.x PMID: 23067351.
69. Keebler ME, Deo RC, Surti A, Konieczkowski D, Guiducci C, Burtt N, et al. Fine-mapping in African Americans of 8 recently discovered genetic loci for plasma lipids: The Jackson Heart Study. Circ Cardiovasc Genet. 2010; 3(4):358-64. doi:10.1161/CIRCGENETICS.109.914267 PMID: 20570916.
70. Carlson CS, Matise TC, North KE, Haiman CA, Fesinmeyer MD, Buyske S, et al. Generalization and dilution of association results from European GWAS in populations of non-European ancestry: The PAGE study. PLOS Biol. 2013; 11(9):e1001661. doi:10.1371/journal.pbio.1001661 PMID: 24068893.
71. Deo RC, Reich D, Tandon A, Akylbekova E, Patterson N, Waliszewska A, et al. Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: The Jackson Heart Study. PLOS genetics. 2009; 5(1):e1000342. doi:10.1371/journal.pgen.1000342 PMID: 19148283.
72. Dumitrescu L, Carty CL, Taylor K, Schumacher FR, Hindorff LA, Ambite JL, et al. Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLOS genetics. 2011; 7(6):e1002138doi:10.1371/journal.pgen.1002138 PMID: 21738485.
73. Liu CT, Monda KL, Taylor KC, Lange L, Demerath EW, Palmas W, et al. Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLOS genetics. 2013; 9(8): e1003681. doi:10.1371/journal.pgen.1003681 PMID: 23966867.
74. Musunuru K, Romaine SP, Lettre G, Wilson JG, Volcik KA, Tsai MY, et al. Multi-ethnic analysis of lipidassociated loci: The NHLBI CARe project. PLOS One. 2012; 7(5):e36473doi:10.1371/journal.pone.0036473PMID: 22629316.
75. Bryant EK, Dressen AS, Bunker CH, Hokanson JE, Hamman RF, Kamboh MI, et al. A multiethnic replication study of plasma lipoprotein levels-associated SNPs identified in recent GWAS. PLOS One. 2013; 8(5):e63469. doi:10.1371/journal.pone.0063469 PMID: 23717430.
76. Lettre G, Palmer CD, Young T, Ejebe KG, Allayee H, Benjamin EJ, et al. Genome-wide association study of coronary heart disease and its risk factors in 8, 090 African Americans: The NHLBI CARe Project. PLOS genetics. 2011; 7(2):e1001300. doi:10.1371/journal.pgen.1001300 PMID: 21347282.
77. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, et al. Prediction of coronary heart disease risk using a genetic risk score: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2007; 166(1):28-35. PMID: 17443022.
78. Havard School of Public Health. EIGENSOFT. Available: http://www.hsph.harvard.edu/alkes-price/software/.
79. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Toutouza M, Papaioannou I, et al. Effects of chronic alcohol consumption on lipid levels, inflammatory and haemostatic factors in the general population: The 'ATTICA' Study. Eur J Cardiovasc Prev Rehabil. 2003; 10(5):355-61. PMID: 14663297.
80. Park H, Kim K. Association of alcohol consumption with lipid profile in hypertensive men. Alcohol Alcohol. 2012; 47(3):282-7. doi:10.1093/alcalc/ags019PMID: 22371847.
81. Foster EM. Instrumental variables for logistic regression: an illustration. Soc Sci Res. 1997; 26(4):487- 504.
82. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993; 329(25):1829-34. PMID: 8247033.
83. Superko HR, Pendyala L, Williams PT, Momary KM, King SB 3rd, Garrett BC. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol. 2012; 6(6):496-523. doi:10.1016/j.jacl.2012.03.001 PMID: 23312047.
84. Williams PT. Fifty-three year follow-up of coronary heart disease versus HDL2 and other lipoproteins in Gofman's Livermore Cohort. J Lipid Res. 2012; 53(2):266-72doi:10.1194/jlr.M019356 PMID: 22128321.
85. Williams PT, Feldman DE. Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort. Atherosclerosis. 2011; 214(1):196-202. doi:10.1016/j.atherosclerosis.2010.10.024 PMID: 21109246.
86. De Oliveira ESER, Foster D, McGee Harper M, Seidman CE, Smith JD, Breslow JL, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation. 2000; 102(19):2347-52. PMID: 11067787.
87. Beulens JW, Sierksma A, van Tol A, Fournier N, van Gent T, Paul JL, et al. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1. J Lipid Res. 2004; 45(9):1716-23. PMID: 15231854.
88. van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF. Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res. 2001; 42(12):2077-83. PMID: 11734581.
89. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The Framingham study. Arterioscler Thromb Vasc Biol. 2000; 20(5):1323-9. PMID: 10807749.
90. Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med. 2004; 255(2):188-205. PMID: 14746556.
91. Brunzell JD. Increased ApoB in small dense LDL particles predicts premature coronary artery disease. Arterioscler Thromb Vasc Biol. 2005; 25(3):474-5. PMID: 15731485.
92. Walldius G, Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J. 2005; 26(3):210-2. PMID: 15618031.
93. Jacobson TA. Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk. Mayo Clin Proc. 2011; 86(8):762-80. doi:10.4065/mcp.2011.0128PMID: 21803958.
94. Contois JH, Warnick GR, Sniderman AD. Reliability of low-density lipoprotein cholesterol, non-highdensity lipoprotein cholesterol, and apolipoprotein B measurement. J Clin Lipidol. 2011; 5(4):264-72. doi:10.1016/j.jacl.2011.05.004PMID: 21784371.